[Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020]

D Thomas-Rüddel1,2, J Winning1, P Dickmann1,2

  • 1Klinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Jena, Am Klinikum 1, 07747, Jena, Deutschland.

Der Anaesthesist
|March 20, 2020
PubMed

Insights

The COVID-19 outbreak in Germany presents with mild to severe cases requiring intensive care. Severe cases show a prolonged lung function decline, unlike sepsis, and require specific management strategies.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Public Health

Background:

  • The novel coronavirus disease (COVID-19) outbreak has impacted Germany.
  • While most infections are mild, severe cases necessitate intensive care.
  • Severe COVID-19 courses exhibit a distinct prolonged progression of lung function deterioration.

Purpose of the Study:

  • To outline the characteristics of severe COVID-19 cases in Germany.
  • To highlight diagnostic approaches for COVID-19.
  • To emphasize critical care management and infection prevention strategies.

Main Methods:

  • Diagnosis is confirmed via Polymerase Chain Reaction (PCR) on respiratory specimens.
  • Clinical observation of disease progression and severity.
  • Review of intensive care unit (ICU) management protocols.

Main Results:

  • Severe Acute Respiratory Distress Syndrome (ARDS) is a key indicator of critical COVID-19 illness.
  • Prolonged respiratory compromise is characteristic of severe disease.
  • Intensive care departments face significant challenges in managing these patients.

Conclusions:

  • Effective prevention of nosocomial infections, including proper personal protective equipment (PPE) use, is crucial.
  • Maintaining hospital operational capacity is vital during the pandemic.
  • Anesthesia, intensive care, and emergency medicine departments must prepare for substantial challenges posed by COVID-19.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
172
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
182
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
593
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.0K
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
497
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
715